ElefteriouF. Regulation of bone remodeling by the central and peripheral nervous system.Arch Biochem Biophys.May 152008; 473(2): 231–236.
2.
KimYS, PaikIY, RhieYJ, SuhSH. Integrative physiology: defined novel metabolic roles of osteocalcin.J Korean Med Sci.Jul2010; 25(7): 985–991.
3.
LeeNK, SowaH, HinoiEEndocrine regulation of energy metabolism by the skeleton.Cell.Aug 102007; 130(3): 456–469.
4.
PalisJ, YoderMC. Yolk-sac hematopoiesis: the first blood cells of mouse and man.Exp Hematol.Aug2001; 29(8): 927–936.
5.
MoritzKM, LimGB, WintourEM. Developmental regulation of erythropoietin and erythropoiesis.Am J Physiol.Dec1997; 273(6 Pt 2):R1829–1844.
6.
BleibergI, PerahG, FeldmanM. Effect of testosterone on the formation of erythroid spleen colonies from fetal liver precursor cells.Blood.Feb1973; 41(2): 285–291.
7.
CongoteLF. Regulation of fetal liver erythropoiesis.J Steroid Biochem.May1977; 8(5): 423–428.
8.
FisherDA. The unique endocrine milieu of the fetus.J Clin Invest.Sep1986; 78(3): 603–611.
9.
GardnerFH, PringleJCJr. Androgens and erythropoiesis. I. Preliminary clinical observations.Arch Intern Med.Jun1961; 107: 846–862.
10.
FisherJW, SamuelsAI, MalgorLA. Androgens and erythropoiesis.Isr J Med Sci.Jul-Aug1971; 7(7): 892–900.
11.
GardnerFH, GorsheinD. Regulation of erythropoiesis by androgens.Trans Am Clin Climatol Assoc.1973; 84: 60–70.
12.
EvensRP, AmersonAB. Androgens and erythropoiesis.J Clin Pharmacol.Feb-Mar1974; 14(2): 94–101.
13.
ANDROGENS and erythropoiesis.Br Med J.Dec 141957; 2(5058): 1422–1423.
14.
AlexanianR. Erythropoietin and erythropoiesis in anemic man following androgens.Blood.Apr1969; 33(4): 564–572.
15.
GerbinoPP. Actions of androgens on erythropoiesis.Hosp Top.Sep-Oct1974; 52(8): 28, 55.
16.
Luque-RamirezM, Mendieta-AzconaC, Alvarez-BlascoF, Escobar-MorrealeHF. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.Hum Reprod.Dec2007; 22(12): 3197–3203.
17.
QuaschningT, RuschitzkaF, StallmachTErythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.FASEB J.Feb2003; 17(2): 259–261.
18.
Pavlovic-KenteraV, BasaraN, JerkicMErythrocytosis in spontaneously hypertensive rats.Exp Hematol.Dec1988; 16(11): 950–953.
WinklerUH. Effects of androgens on haemostasis.Maturitas.Jul1996; 24(3): 147–155.
24.
HalushkaPV, MasudaA, MatsudaK. The Gordon Wilson Lecture. Regulation of thromboxane A2 receptors by testosterone: implications for steroid abuse and cardiovascular disease.Trans Am Clin Climatol Assoc.1994; 105: 95–103.
25.
NohJY, LimKM, BaeONProcoagulant and prothrombotic activation of human erythrocytes by phosphatidic acid.Am J Physiol Heart Circ Physiol.Aug2010; 299(2): H347-355.
26.
SantosMT, VallesJ, LagoAResidual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease.J Thromb Haemost.Apr2008; 6(4): 615–621.
27.
VallesJ, SantosMT, AznarJErythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.Circulation.Feb 31998; 97(4): 350–355.
28.
SantosMT, VallesJ, AznarJ, MarcusAJ, BroekmanMJ, SafierLB. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin.Circulation.Jan 71997; 95(1): 63–68.
29.
SmithMR, LeeH, NathanDM. Insulin sensitivity during combined androgen blockade for prostate cancer.J Clin Endocrinol Metab.Apr2006; 91(4): 1305–1308.
30.
Lopez-BermejoA, DiazM, MoranE, de ZegherF, IbanezL. A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess.Diabetes Care.Jul2010; 33(7): 1544–1548.
31.
SmithR, MannN, MakelainenH, RoperJ, BraueA, VarigosG. A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial.Mol Nutr Food Res.Jun2008; 52(6): 718–726.
32.
EnglishKM, MandourO, SteedsRP, DiverMJ, JonesTH, ChannerKS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.Eur Heart J.Jun2000; 21(11): 890–894.
33.
JonesRD, MalkinCJ, ChannerKS, JonesTH. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: further supportive data.J Clin Endocrinol Metab.Mar2003; 88(3): 1403–1404; author reply 1404.
34.
HakAE, WittemanJC, de JongFH, GeerlingsMI, HofmanA, PolsHA. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study.J Clin Endocrinol Metab.Aug2002; 87(8): 3632–3639.
35.
KupelianV, PageST, AraujoAB, TravisonTG, BremnerWJ, McKinlayJB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.J Clin Endocrinol Metab.Mar2006; 91(3): 843–850.
36.
HulleyS, GradyD, BushTRandomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.JAMA.Aug 191998; 280(7): 605–613.
37.
RossouwJE, AndersonGL, PrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.JAMA.Jul 172002; 288(3): 321–333.
JenkinsJS. The voice of the castrato.Lancet. Jun 20 1998; 351(9119): 1877–1880.
40.
PaternostroG. Longevity and testosterone.Nature. Mar 31 1994; 368(6470): 408.
41.
StenholmS, MetterEJ, RothGSRelationship between plasma ghrelin, insulin, leptin, interleukin 6, adiponectin, testosterone and longevity in the Baltimore Longitudinal Study of Aging.Aging Clin Exp Res.Apr2011; 23(2): 153–158.
42.
ToulisKA, GoulisDG, MintzioriGMeta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome.Hum Reprod Update.Nov-Dec2011; 17(6): 741–760.
43.
TalbottEO, ZborowskiiJV, BoudrauxMY. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.Minerva Ginecol.Feb2004; 56(1): 27–39.
44.
LoucksTL, TalbottEO, McHughKP, KeelanM, BergaSL, GuzickDS. Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?Fertil Steril. Sep 2000; 74(3): 547–552.
45.
WildS, PierpointT, McKeigueP, JacobsH. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.Clin Endocrinol (Oxf).May2000; 52(5): 595–600.
46.
DogramaciAC, BalciDD, BalciAIs androgenetic alopecia a risk for atherosclerosis?J Eur Acad Dermatol Venereol. Feb 23 2009.
47.
RasmusonS, NasmanB, CarlstromK, OlssonT. Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease.Dement Geriatr Cogn Disord.2002; 13(2): 74–79.
48.
LiuPY, DeathAK, HandelsmanDJ. Androgens and cardiovascular disease.Endocr Rev.Jun2003; 24(3): 313–340.
49.
HeinleinCA, ChangC. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions.Mol Endocrinol.Oct2002; 16(10): 2181–2187.
50.
MichelsG, HoppeUC. Rapid actions of androgens.Front Neuroendocrinol.May2008; 29(2): 182–198.
51.
ReisnerEHJr. Tissue culture of bone marrow. II. Effect of steroid hormones on hematopoiesis in vitro.Blood.Apr1966; 27(4): 460–469.
TanriverdiF, SilveiraLF, MacCollGS, BoulouxPM. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity.J Endocrinol.Mar2003; 176(3): 293–304.
54.
MasoodDE, RoachEC, BeauregardKG, KhalilRA. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.Curr Drug Metab.Oct2010; 11(8): 693–714.
55.
HammondCB, SoulesM. Clinical significance of estrogen metabolism and physiology.Contemp Ob/Gyn1978; 11: 41.
DickersonSM, GoreAC. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle.Rev Endocr Metab Disord.Jun2007; 8(2): 143–159.
58.
MatthewsJ, GustafssonJA. Estrogen signaling: a subtle balance between ER alpha and ER beta.Mol Interv.Aug2003; 3(5): 281–292.
59.
ZhaoC, Dahlman-WrightK, GustafssonJA. Estrogen receptor beta: an overview and update.Nucl Recept Signal.2008; 6: e003.
60.
HurvitzSA, PietrasRJ. Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions.Cancer. Nov 1 2008; 113(9): 2385–2397.
61.
ZhuBT, ConneyAH. Functional role of estrogen metabolism in target cells: review and perspectives.Carcinogenesis.Jan1998; 19(1): 1–27.
62.
PfefferU, FecarottaE, VidaliG. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells.Cancer Res. May 15 1995; 55(10): 2158–2165.
63.
NelsonLR, BulunSE. Estrogen production and action.J Am Acad Dermatol.Sep2001; 45(3 Suppl):S116–124.
64.
FeigelsonHS, McKean-CowdinR, PikeMCCytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy.Cancer Res. Aug 15 1999; 59(16): 3908–3910.
65.
al-AzzawiF, WahabM. Estrogen and colon cancer: current issues.Climacteric.Mar2002; 5(1): 3–14.
66.
CrandallCJ. Estrogen replacement therapy and colon cancer: a clinical review.J Womens Health Gend Based Med.Nov1999; 8(9): 1155–1166.
67.
XuX, ThomasML. Biphasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity estrogen binding sites.Endocrine.Sep1995; 3(9): 661–665.
68.
MutiP. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence.Recent Results Cancer Res.2005; 166: 245–256.
69.
FusterJJ, AndresV. Telomere biology and cardiovascular disease.Circ Res. Nov 24 2006; 99(11): 1167–1180.
70.
OkudaT, SekizawaA, PurwosunuYGenetics of endometrial cancers.Obstet Gynecol Int.2010; 2010: 984013.
71.
von DadelszenP, WatsonRW, NoorwaliFMaternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction.Am J Obstet Gynecol.Aug1999; 181(2): 408–414.
72.
NathanC. Neutrophils and immunity: challenges and opportunities.Nat Rev Immunol.Mar2006; 6(3): 173–182.
73.
ParkJE, BarbulA. Understanding the role of immune regulation in wound healing.Am J Surg.May2004; 187(5A):11S–16S.
74.
HusseinOA, El-ToukhyMA, El-RahmanHS. Neutrophil CD64 expression in inflammatory autoimmune diseases: its value in distinguishing infection from disease flare.Immunol Invest.2010; 39(7): 699–712.
75.
NemethT, FutosiK, HablyCNeutrophil functions and autoimmune arthritis in the absence of p190RhoGAP: generation and analysis of a novel null mutation in mice.J Immunol.Sep 12010; 185(5): 3064–3075.
76.
LiuZ, GiudiceGJ, ZhouXA major role for neutrophils in experimental bullous pemphigoid.J Clin Invest.Sep 11997; 100(5): 1256–1263.
77.
HofmanPM. Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis.World J Gastroenterol.Dec 142010; 16(46): 5790–5800.
78.
BalkwillF, MantovaniA. Inflammation and cancer: back to Virchow? Lancet.Feb 172001; 357(9255): 539–545.
BorrelloMG, Degl'InnocentiD, PierottiMA. Inflammation and cancer: the oncogene-driven connection.Cancer Lett.Aug 282008; 267(2): 262–270.
81.
BauerM, EickhoffJC, GouldMN, MundhenkeC, MaassN, FriedlA. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer.Breast Cancer Res Treat.Apr2008; 108(3): 389–397.
82.
FairweatherD, Frisancho-KissS, RoseNR. Sex differences in autoimmune disease from a pathological perspective.Am J Pathol.Sep2008; 173(3): 600–609.
83.
PietrograndeL, RaimondoE, FossaliA, ZaolinoC. Biological and pharmacological factors influencing the fracture healing.Aging Clin Exp Res.Apr2011; 23(2 Suppl):65–68.
84.
CampbellL, EmmersonE, DaviesFEstrogen promotes cutaneous wound healing via estrogen receptor beta independent of its antiinflammatory activities.J Exp Med.Aug 302010; 207(9): 1825–1833.
85.
HardmanMJ, AshcroftGS. Estrogen, not intrinsic aging, is the major regulator of delayed human wound healing in the elderly.Genome Biol.2008; 9(5): R80.
86.
MillsSJ, AshworthJJ, GilliverSC, HardmanMJ, AshcroftGS. The sex steroid precursor DHEA accelerates cutaneous wound healing via the estrogen receptors.J Invest Dermatol.Nov2005; 125(5): 1053–1062.
AshcroftGS, Greenwell-WildT, HoranMA, WahlSM, FergusonMW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response.Am J Pathol.Oct1999; 155(4): 1137–1146.
89.
WalkerSE. Estrogen and autoimmune disease.Clin Rev Allergy Immunol.Feb2011; 40(1): 60–65.
90.
OstensenM. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus.Ann N Y Acad Sci.Jun 221999; 876: 131–143; discussion 144.
91.
CraftsRG. The effects of estrogens on the bone marrow of adult female dogs.Blood.Mar1948; 3(3): 276–285.
92.
MolloyEJ, O'NeillAJ, GranthamJJSex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone.Blood.Oct 12003; 102(7): 2653–2659.
93.
HarkonenPL, VaananenHK. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators.Ann N Y Acad Sci. Nov 2006; 1089: 218–227.
94.
Ben-HurH, MorG, InslerVMenopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes.Am J Reprod Immunol.Dec1995; 34(6): 363–369.
95.
Ziegler-HeitbrockL. The CD14+ CD16+ blood monocytes: their role in infection and inflammation.J Leukoc Biol.Mar2007; 81(3): 584–592.
96.
LiY, LeePY, ReevesWH. Monocyte and macrophage abnormalities in systemic lupus erythematosus.Arch Immunol Ther Exp (Warsz).Oct2010; 58(5): 355–364.
97.
SweetenTL, PoseyDJ, McDougleCJ. High blood monocyte counts and neopterin levels in children with autistic disorder.Am J Psychiatry.Sep2003; 160(9): 1691–1693.
98.
RivierA, PeneJ, RabesandratanaH, ChanezP, BousquetJ, CampbellAM. Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages.Clin Exp Immunol.May1995; 100(2): 314–318.
99.
FingerleG, PforteA, PasslickB, BlumensteinM, StrobelM, Ziegler-HeitbrockHW. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.Blood.Nov 151993; 82(10): 3170–3176.
100.
SeliE, SelamB, MorG, KayisliUA, PehlivanT, AriciA. Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect.Menopause.Jul-Aug2001; 8(4): 296–301.
101.
HongYJ, JeongMH, AhnYRelationship between peripheral monocytosis and nonrecovery of left ventricular function in patients with left ventricular dysfunction complicated with acute myocardial infarction.Circ J.Aug2007; 71(8): 1219–1224.
102.
BeranM, ShenY, OnidaF, WenS, KantarjianH, EsteyE. Prognostic significance of monocytosis in patients with myeloproliferative disorders.Leuk Lymphoma.Mar2006; 47(3): 417–423.
103.
EconomopoulosT, StathakisN, MaragoyannisZ, GardikasE, DervenoulasJ. Myelodysplastic syndrome. Clinical and prognostic significance of monocyte count, degree of blastic infiltration, and ring sideroblasts.Acta Haematol.1981; 65(2): 97–102.
104.
FenauxP, BeuscartR, LaiJL, JouetJP, BautersF. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases.J Clin Oncol.Sep1988; 6(9): 1417–1424.
105.
JaworkowskyLI, SoloveyDY, RhausovaLY, UdrisOY. Monocytosis as a sign of subsequent leukemia in patients with cytopenias (preleukemia).Folia Haematol Int Mag Klin Morphol Blutforsch.1983; 110(3): 395–401.
106.
OwenG, LewisIJ, MorganM, RobinsonA, StevensRF. Prognostic factors in juvenile chronic granulocytic leukaemia.Br J Cancer Suppl.Aug1992; 18: S68–71.
107.
TakasakiY, IwanagaM, TsukasakiKImpact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL).Leuk Res.Jun2007; 31(6): 751–757.
108.
SimonJA. Safety of estrogen/androgen regimens.J Reprod Med.Mar2001; 46(3 Suppl):281–290.
109.
McCrohonJA, JessupW, HandelsmanDJ, CelermajerDS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1.Circulation.May 41999; 99(17): 2317–2322.
110.
ThornGW, ForshamPHA test for adrenal cortical insufficiency; the response to pituitary andrenocorticotropic hormone.J Am Med Assoc.Jul 171948; 137(12): 1005–1009.
111.
GiembyczMA, LindsayMA. Pharmacology of the eosinophil.Pharmacol Rev.Jun1999; 51(2): 213–340.
112.
BeishuizenA, ThijsLG. Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab.Dec2001; 15(4): 513–531.
113.
BeishuizenA, VermesI, HylkemaBS, HaanenC. Relative eosinophilia and functional adrenal insufficiency in critically ill patients.Lancet.May 151999; 353(9165): 1675–1676.
114.
NewtonR. Molecular mechanisms of glucocorticoid action: what is important? Thorax.Jul2000; 55(7): 603–613.
115.
SabagN, CastrillonMA, TchernitchinA. Cortisol-induced migration of eosinophil leukocytes to lymphoid organs.Experientia.May 151978; 34(5): 666–667.
116.
OhtsuH. Progress in allergy signal research on mast cells: the role of histamine in immunological and cardiovascular disease and the transporting system of histamine in the cell.J Pharmacol Sci.Mar2008; 106(3): 347–353.
117.
Dimova-YanevaD, RussellD, MainM, BrookerRJ, HelmsPJ. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis.Clin Exp Allergy.Apr2004; 34(4): 555–558.
118.
GarofaloR, DorrisA, AhlstedtS, WelliverRC. Peripheral blood eosinophil counts and eosinophil cationic protein content of respiratory secretions in bronchiolitis: relationship to severity of disease.Pediatr Allergy Immunol.May1994; 5(2): 111–117.
119.
KimCK, KimSW, KimYKBronchoalveolar lavage eosinophil cationic protein and interleukin-8 levels in acute asthma and acute bronchiolitis.Clin Exp Allergy.May2005; 35(5): 591–597.
120.
KimHH, LeeMH, LeeJS. Eosinophil cationic protein and chemokines in nasopharyngeal secretions of infants with respiratory syncytial virus (RSV) bronchiolitis and non-RSV bronchiolitis.J Korean Med Sci.Feb2007; 22(1): 37–42.
121.
PhippsS, LamCE, MahalingamSEosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus.Blood.Sep 12007; 110(5): 1578–1586.
122.
PriftisKN, PapadopoulouA, LiatsisE, KatsikasD, NicolaidouP, KanariouM. Serum eosinophil cationic protein and CD23 in acute RSV bronchiolitis.Med Sci Monit.Oct2005; 11(10): CR493–497.
123.
RosenbergHF. RNase A ribonucleases and host defense: an evolving story.J Leukoc Biol.May2008; 83(5): 1079–1087.
124.
RosenbergHF, DomachowskeJB. Eosinophils, ribonucleases and host defense: solving the puzzle.Immunol Res.1999; 20(3): 261–274.
125.
RosenbergHF, DomachowskeJB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens.J Leukoc Biol.Nov2001; 70(5): 691–698.
126.
ThorneKJ, RichardsonBA, VeithMC, TaiPC, SpryCJ, ButterworthAE. Partial purification and biological properties of an eosinophil-activating factor.Eur J Immunol.Nov1985; 15(11): 1083–1091.
127.
MingomatajEC. Eosinophil-induced prognosis improvement of solid tumors could be enabled by their vesicle-mediated barrier permeability induction.Med Hypotheses.2008; 70(3): 582–584.
HeidenfelderB, JohnsonM, HudgensEIncreased plasma reactive oxidant levels and their relationship to blood cells, total IgE, and allergen-specific IgE levels in asthmatic children.J Asthma.Sep2009; 46(7): 687–691.
130.
KahnJE, Dutoit-LefevreV, Duban-DeweerSComparative proteomic analysis of blood eosinophils reveals redox signaling modifications in patients with FIP1L1-PDGFRA-associated chronic eosinophilic leukemia.J Proteome Res. Feb 8 2011.
131.
Kuo ChouTN, LiYS, LueKHGenetic polymorphism of manganese superoxide dismutase is associated with childhood asthma.J Asthma.Jun2010; 47(5): 532–538.
132.
LeeYA, ShinMH. Mitochondrial respiration is required for activation of ERK1/2 and caspase-3 in human eosinophils stimulated with hydrogen peroxide.J Investig Allergol Clin Immunol.2009; 19(3): 188–194.
133.
TripathiP, NairS, SinghBP, AroraN. Mutated glutathione S-transferase in combination with reduced glutathione shows a synergistic effect in ameliorating oxidative stress and airway inflammation.Free Radic Biol Med.Mar 152010; 48(6): 839–844.
134.
JutelM, BlaserK, AkdisCA. The role of histamine in regulation of immune responses.Chem Immunol Allergy.2006; 91: 174–187.
OchensbergerB, DaeppGC, RihsS, DahindenCA. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation.Blood.Oct 151996; 88(8): 3028–3037.
137.
LantzCS, BoesigerJ, SongCHRole for interleukin-3 in mast-cell and basophil development and in immunity to parasites.Nature.Mar 51998; 392(6671): 90–93.
138.
FalconeFH, HaasH, GibbsBF. The human basophil: a new appreciation of its role in immune responses.Blood.Dec 152000; 96(13): 4028–4038.
139.
FauciAS, DaleDC. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.J Clin Invest.Jan1974; 53(1): 240–246.
140.
HaynesBF, FauciAS. The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes.J Clin Invest.Mar1978; 61(3): 703–707.
141.
GattiG, CavalloR, SartoriMLInhibition by cortisol of human natural killer (NK) cell activity.J Steroid Biochem.Jan1987; 26(1): 49–58.
142.
MaseraR, GattiG, SartoriMLInvolvement of Ca2+-dependent pathways in the inhibition of human natural killer (NK) cell activity by cortisol.Immunopharmacology.Jul-Aug1989; 18(1): 11–22.
143.
MendelsohnJ, MulterMM, BernheimJL. Inhibition of human lymphocyte stimulation by steroid hormones: cytokinetic mechanisms.Clin Exp Immunol.Jan1977; 27(1): 127–134.
144.
Ansar AhmedS, PenhaleWJ, TalalN. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.Am J Pathol.Dec1985; 121(3): 531–551.
145.
GaberscekS, ZaletelK. Thyroid physiology and autoimmunity in pregnancy and after delivery.Expert Rev Clin Immunol.Sep2011; 7(5): 697–706; quiz 707.
146.
KuijpensJL, De Hann-MeulmanM, VaderHL, PopVJ, WiersingaWM, DrexhageHA. Cell-mediated immunity and postpartum thyroid dysfunction: a possibility for the prediction of disease?J Clin Endocrinol Metab. Jun 1998; 83(6): 1959–1966.
147.
GerhardI, WaibelS, DanielV, RunnebaumB. Impact of heavy metals on hormonal and immunological factors in women with repeated miscarriages.Hum Reprod Update.May-Jun1998; 4(3): 301–309.
148.
HoermannR, EcklW, HoermannC, LarischR. Complex relationship between free thyroxine and TSH in the regulation of thyroid function.Eur J Endocrinol.Jun2010; 162(6): 1123–1129.
149.
Christ-CrainM, MeierC, HuberP, ZulewskiH, StaubJJ, MullerB. Effect of restoration of euthyroidism on peripheral blood cells and erythropoietin in women with subclinical hypothyroidism.Hormones (Athens).Oct-Dec2003; 2(4): 237–242.
BizzozeroJ. Ueber einen neuen Formbestandtheil des Blutes und dessen Rolle bei der Thrombose und der Blutgerinnung.Virchows Archiv.1882; 90(2): 261–332.
152.
SchmidtMB, ChenEH, LynchSE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair.Osteoarthritis Cartilage.May2006; 14(5): 403–412.
153.
TennantM, McGeachieJK. Platelet-derived growth factor and its role in atherogenesis: a brief review.Aust N Z J Surg.Jul1991; 61(7): 482–488.
154.
AdelsonE, RheingoldJJ, CrosbyWH. The platelet as a sponge: a review.Blood.Jun1961; 17: 767–774.
155.
GershonMD. Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility.Aliment Pharmacol Ther.Nov2004; 20 Suppl 7:3–14.
156.
EmilianoAB, FudgeJL. From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.Neuropsychopharmacology.May2004; 29(5): 833–846.
157.
HaneyEM, ChanBK, DiemSJAssociation of low bone mineral density with selective serotonin reuptake inhibitor use by older men.Arch Intern Med.Jun 252007; 167(12): 1246–1251.
158.
HaneyEM, WardenSJ. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.J Musculoskelet Neuronal Interact.Apr-Jun2008; 8(2): 133–145.
159.
WeyrichAS, ZimmermanGA. Platelets: signaling cells in the immune continuum.Trends Immunol.Sep2004; 25(9): 489–495.
160.
SaxenaSP, McNicolA, BrandesLJ, BeckerAB, GerrardJM. A role for intracellular histamine in collagen-induced platelet aggregation.Blood.Jan 151990; 75(2): 407–414.
161.
EckardtKU. Managing a fateful alliance: anaemia and cardiovascular outcomes.Nephrol Dial Transplant.Jun2005; 20 Suppl 6:vi16–20.
162.
AnandIS. Heart failure and anemia: mechanisms and pathophysiology.Heart Fail Rev.Dec2008; 13(4): 379–386.
163.
MetivierF, MarchaisSJ, GuerinAP, PannierB, LondonGM. Pathophysiology of anaemia: focus on the heart and blood vessels.Nephrol Dial Transplant.2000; 15 Suppl 3:14–18.
164.
GlickG, PlauthWHJr., BraunwaldE. Role of the Autonomic Nervous System in the Circulatory Response to Acutely Induced Anemia in Unanesthetized Dogs.J Clin Invest.Nov1964; 43: 2112–2124.
165.
VoorhessML, StuartMJ, StockmanJA, OskiFA. Iron deficiency anemia and increased urinary norepinephrine excretion.J Pediatr.Apr1975; 86(4): 542–547.
166.
WagnerA, FortierN, GirouxA, LukesJ, SnyderLM. Catecholamines in adult iron deficiency patients.Experientia.May 151979; 35(5): 681–682.
167.
GroeneveldD, SmeetsHG, KabraPM, DallmanPR. Urinary catecholamines in iron-deficient rats at rest and following surgical stress.Am J Clin Nutr.Aug1985; 42(2): 263–269.
168.
HwangYC, JeongIK, AhnKJ, ChungHY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects.Diabetes Metab Res Rev.Nov2009; 25(8): 768–772.
169.
ImJA, YuBP, JeonJY, KimSH. Relationship between osteocalcin and glucose metabolism in postmenopausal women.Clin Chim Acta.Oct2008; 396(1-2): 66–69.
170.
KindblomJM, OhlssonC, LjunggrenOPlasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men.J Bone Miner Res.May2009; 24(5): 785–791.
171.
MunzerT, RosenCJ, HarmanSMEffects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.Am J Physiol Endocrinol Metab.May2006; 290(5): E1006-1013.
172.
KulakCA, Baz-HechtM, NievesJ, ShenV, LindsayR, CosmanF. Responses of Urinary N-Telopeptide and Renal Calcium Handling to PTH Infusion after Treatment with Estrogen, Raloxifene, and Tamoxifen.Calcif Tissue Int. Feb 5 2012.
173.
ErnstM, SchmidC, FroeschER. Enhanced osteoblast proliferation and collagen gene expression by estradiol.Proc Natl Acad Sci U S A.Apr1988; 85(7): 2307–2310.
174.
DiSilvioL, JamesonJ, GamieZ, GiannoudisPV, TsiridisE. In vitro evaluation of the direct effect of estradiol on human osteoblasts (HOB) and human mesenchymal stem cells (h-MSCs).Injury.Sep2006; 37 Suppl 3:S33–42.
175.
BaqiL, PayerJ, KillingerZThyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.Endocr Regul.Apr2010; 44(2): 57–63.
176.
BaqiL, PayerJ, KillingerZThe level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.Endocr Regul.Jan2010; 44(1): 9–15.
177.
GuoCY, WeetmanAP, EastellR. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.Clin Endocrinol (Oxf).Mar1997; 46(3): 301–307.
178.
TarleM. Plasma osteocalcin values and related hormonal parameters in patients subjected to a variety of prostate anticancer agents.Urol Res.1991; 19(1): 39–44.
179.
YeungF, LawWK, YehCHRegulation of human osteocalcin promoter in hormone-independent human prostate cancer cells.J Biol Chem.Jan 252002; 277(4): 2468–2476.
180.
MossDW. Diagnostic aspects of alkaline phosphatase and its isoenzymes.Clin Biochem.Aug1987; 20(4): 225–230.
181.
OrimoH. The mechanism of mineralization and the role of alkaline phosphatase in health and disease.J Nippon Med Sch.Feb2010; 77(1): 4–12.
182.
MagnussonP, DegerbladM, SaafM, LarssonL, ThorenM. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.J Bone Miner Res.Feb1997; 12(2): 210–220.
183.
StepanJ, HavranekT, FormankovaJ, SkrhaJ, SkrhaF, PacovskyV. Bone isoenzyme of serum alkaline phosphatase in diabetes mellitus.Clin Chim Acta.Jul 171980; 105(1): 75–81.
184.
AlievM, GuzunR, Karu-VarikmaaM, KaambreT, WallimannT, SaksV. Molecular System Bioenergics of the Heart: Experimental Studies of Metabolic Compartmentation and Energy Fluxes versus Computer Modeling.Int J Mol Sci.2011; 12(12): 9296–9331.
185.
WallimannT, HemmerW. Creatine kinase in non-muscle tissues and cells.Mol Cell Biochem.Apr-May1994; 133-134:193–220.
NewsholmeEA, BeisI, LeechAR, ZammitVA. The role of creatine kinase and arginine kinase in muscle.Biochem J.Jun 151978; 172(3): 533–537.
190.
KhanHA, AlhomidaAS, SobkiSH, MoghairiAA, KoronkiHE. Blood cell counts and their correlation with creatine kinase and C-reactive protein in patients with acute myocardial infarction.Int J Clin Exp Med.2012; 5(1): 50–55.
191.
KarrasDJ, KaneDL. Serum markers in the emergency department diagnosis of acute myocardial infarction.Emerg Med Clin North Am.May2001; 19(2): 321–337.
192.
GreenSM, VowelsJ, WatermanB, RothrockSG, KuniyoshiG. Leukocytosis: a new look at an old marker for acute myocardial infarction.Acad Emerg Med.Nov1996; 3(11): 1034–1041.
193.
PaulGK, SenB, BariMACorrelation of platelet count and acute ST-elevation in myocardial infarction.Mymensingh Med J.Jul2010; 19(3): 469–473.
194.
VermeulenRC, KurkRM, VisserFC, SluiterW, ScholteHR. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity.J Transl Med.2010; 8: 93.
195.
Diaz-OlmosR, NogueiraAC, PenalvaDQ, LotufoPA, BensenorIM. Frequency of subclinical thyroid dysfunction and risk factors for cardiovascular disease among women at a workplace.Sao Paulo Med J.Jan2010; 128(1): 18–23.
196.
HaentjensP, Van MeerhaegheA, PoppeK, VelkeniersB. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies.Eur J Endocrinol.Sep2008; 159(3): 329–341.
197.
RodondiN, BauerDC, CappolaARSubclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study.J Am Coll Cardiol.Sep 302008; 52(14): 1152–1159.
198.
BurnettJR, CrookeMJ, DelahuntJW, FeekCM. Serum enzymes in hypothyroidism.N Z Med J.Sep 141994; 107(985): 355–356.
199.
SahaB, MaityC. Alteration of serum enzymes in primary hypothyroidism.Clin Chem Lab Med.Jun2002; 40(6): 609–611.
200.
HekimsoyZ, OktemIK. Serum creatine kinase levels in overt and subclinical hypothyroidism.Endocr Res.2005; 31(3): 171–175.
201.
BeyerIW, KarmaliR, Demeester-MirkineN, CoganE, FussMJ. Serum creatine kinase levels in overt and subclinical hypothyroidism.Thyroid.Nov1998; 8(11): 1029–1031.
KaracaliogluO, ArslanZ, KilicS, OzturkE, OzguvenM. Baseline serum levels of cardiac biomarkers in patients with stable coronary artery disease.Biomarkers.Sep-Oct2007; 12(5): 533–540.
204.
FeronO. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.Radiother Oncol.Sep2009; 92(3): 329–333.
205.
KatoGJ, McGowanV, MachadoRFLactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.Blood.Mar 152006; 107(6): 2279–2285.
206.
MansurogluD, OmerogluSN, IzgiALDH levels and left atrial ultrastructural chances in patients with mitral paraprosthetic regurgitation.J Card Surg.May-Jun2005; 20(3): 229–233.
207.
BienE, BalcerskaA. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].Med Wieku Rozwoj.Oct-Dec2004; 8(4 Pt 2):1081–1089.
208.
PuiCH, DodgeRK, DahlGVSerum lactic dehydrogenase level has prognostic value in childhood acute lymphoblastic leukemia.Blood.Oct1985; 66(4): 778–782.
209.
DraouiN, FeronO. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments.Dis Model Mech.Nov2010; 4(6): 727–732.
210.
DuttonCM, JobaW, SpitzwegC, HeufelderAE, BahnRS. Thyrotropin receptor expression in adrenal, kidney, and thymus.Thyroid.Dec1997; 7(6): 879–884.
211.
RobbinsRJ, LeidyJWJr., LandonRM. The effects of growth hormone, prolactin, corticotropin, and thyrotropin on the production and secretion of somatostatin by hypothalamic cells in vitro.Endocrinology.Aug1985; 117(2): 538–543.
212.
BanuKS, AruldhasMM. Sex steroids regulate TSH-induced thyroid growth during sexual maturation in Wistar rats.Exp Clin Endocrinol Diabetes.Jan2002; 110(1): 37–42.
213.
MorleyJE. Extrahypothalamic thyrotropin releasing hormone (TRH) - its distribution and its functions.Life Sci.Oct 291979; 25(18): 1539–1550.
214.
MortimerCH, BesserGM, McNeillyAS, TunbridgeWM, Gomez-PanA, HallR. Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination.Clin Endocrinol (Oxf).Oct1973; 2(4): 317–326.
215.
SingerGG, BrennerBM. Fluid and electrolyte disturbances. In: KasperDL, HarrisonTR, eds. Harrison's principles of internal medicine.16th ed.New York: McGraw-Hill, Medical Pub. Division; 2005:2 v. (xxvii, 2607, [2615, 2128] p.).
216.
DurandD, PampilloM, CarusoC, LasagaM. Role of metabotropic glutamate receptors in the control of neuroendocrine function.Neuropharmacology.Sep2008; 55(4): 577–583.